Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We reiterate our Outperform recommendation on ProAssurance Corporation (PRA - Analyst Report) based on the company’s improved top line, operating cash flows and asset position. Geographic diversity, aggressive claims defense, stable ratings and improving return on equity are the other positives.

ProAssurance will likely release its second-quarter 2012 financial results on August 6. The current Zacks Consensus Estimate for earnings is pegged at $1.52 per share, representing an estimated year-over-year decline of 12.6%.

ProAssurance’s top line is showing gradual improvement while a cut in expenses is also boosting the bottom line and operating dynamics. Moreover, claims loss severity trends continue to remain lower than expected, thereby contributing to the fall in expenses. This is also reflected in total expenses, which declined 16% and 1.4%, respectively, from the prior-year periods in 2011 and the first quarter of 2012.

Additionally, ProAssurance has significantly expanded its geographic footprint through successful acquisition as well as the integration of companies and books of business. The acquisition of Medmarc, announced in June 2012, is expected to substantially boost ProAssurance’s underwriting ability, as Medmarc is one of the leading underwriters of products liability insurance for medical technology and life sciences in the U.S.

Moreover, following the merger with Independent Nevada Doctors Insurance Exchange (INDIE), also announced in June, ProAssurance is expected to emerge as the leading writer of medical professional liability in Nevada by a huge margin as INDIE is Nevada’s leading medical professional liability insurer based on direct written premiums while ProAssurance currently occupies the fourth position in the state. The company is also trying to boost its operating efficiency by merging its subsidiaries to simplify its business structure.

However, ProAssurance’s core business has been witnessing substantial volatility over the past several years. Net premiums written declined in 2007 and 2008, although some recovery was witnessed in 2009. However, net premiums written continued to decline in 2010, which was followed by a recovery in 2011 and the first quarter of 2012.

Another major risk is associated with ProAssurance’s investment portfolio, which primarily consists of fixed income securities. The declining interest rate forces the company to reinvest its matured investments at comparatively lower interest rates, which leads to declining investment income. Nevertheless, the positives of the company outweigh the negatives in our opinion.

ProAssurance, which competes with Berkshire Hathaway Inc. (BRK.A - Snapshot Report) and MontpelierRe Holdings Ltd. (MRH - Analyst Report), carries a Zacks #2 Rank, implying a short-term Buy rating.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTERNATIONA ICAGY 33.30 +5.38%